VANGUARD GROUP INC 13D and 13G filings for Cardlytics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-29 11:23 am Purchase | 2025-06-30 | 13G | CARDLYTICS INC CDLX | VANGUARD GROUP INC | 2,416,909 4.600% | 263,119 (+12.22%) | Filing |
| 2024-02-13 5:00 pm Sale | 2023-12-29 | 13G | CARDLYTICS INC CDLX | VANGUARD GROUP INC | 2,153,790 5.490% | -238,967 (-9.99%) | Filing |
| 2023-02-09 11:12 am Sale | 2022-12-30 | 13G | CARDLYTICS INC CDLX | VANGUARD GROUP INC | 2,392,757 7.210% | -512,285 (-17.63%) | Filing |
| 2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | CARDLYTICS INC CDLX | VANGUARD GROUP INC | 2,905,042 8.730% | 1,068,299 (+58.16%) | Filing |